Sagimet Biosciences (SGMT) Research & Development (2022 - 2026)

Sagimet Biosciences' Research & Development history runs 5 years deep, the most recent figure standing at $7.0 million for Q1 2026.

• In Q1 2026, Research & Development fell 54.41% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $30.7 million (down 36.72% YoY), while the FY2025 annual figure was $39.1 million, up 1.59% from the prior year.
• Research & Development for Q1 2026 stood at $7.0 million, up from $6.7 million in the prior quarter.
• The five-year high for Research & Development was $15.3 million in Q1 2025, with the low at $4.5 million in Q1 2023.
• The 5-year median for Research & Development is $6.6 million (2022), against an average of $7.7 million.
• The sharpest annual moves came in 2025 and 2026: Research & Development surged 191.56% in 2025, then sank 54.41% in 2026.
• Sagimet Biosciences' Research & Development stood at $5.8 million in 2022, then slipped by 3.27% to $5.7 million in 2023, then surged by 151.34% to $14.2 million in 2024, then tumbled by 52.63% to $6.7 million in 2025, then grew by 3.88% to $7.0 million in 2026.
• Business Quant data shows SGMT's Research & Development at $7.0 million in Q1 2026, $6.7 million in Q4 2025, and $9.7 million in Q3 2025.